Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

Read full text
Authors: Julia Bielicki, Michelle Clements, Victor Musiime, David P. Moore, Muhammad Sidat, Veronica Mulenga, Constantine Mutata, Damalie Nalwanga, Zainab Waggie, Josina Chilundo, Chishala Chabala, Mutsawashe Bwakura-Dangarembizi
+88 more Moherndran Archary, Andrew Kiggwe, Ziyaad Dangor, Ben Spittle, Monica Kapasa, A. Tagoola, Charity Jeki, Jahit Sacarlal, W Chris Buck, Shula Chanda, Hilda A Mujuru, Carlo Giaquinto, Shabir A. Madhi, A Sarah Walker, Mike Sharland, Cláudia Massitela, Winete Joaquim, Alice Maieca, Uneisse Cassia, Quim Adriano, Elias Manjate, Sónia Martins, Nádia Manjate, Mara Bombe, Eleutéria Macanze, Sheila Nhacumba, Faiaz Issa, Natércia Florindo, Ana Sigaúque, Rosalina Chilengue, NJ Klein, Leatitia Kampiire, Anne Derache, Samkelisiwe Buthelezi, Senamile Makari, Sandisiwe Nkosi, Sihle Zindela, Nomhle Nkumana, Ntombi Khumalo, Lethabo Nkosi, Tshepiso Msibi, Brandon Jones, Lora Frank, Monica Kapasa, Gae Mundundu, Patricia Ngoma, Jacqueline H. Kaira, Oliver Mwenechanya, Anne Chimolula, Bwalya Simunyola, Martha Sakala, Joyce C. Lungu, Chimuka Kwale, Dorothy Zangata, N. Mumba, Jacqueline Mulako, Mundimba Makwamba, Frederick Chansa, Carolyn Zulu, Kusum J. Nathoo, Ennie Chidziva, Shepherd Mudzingwa, Misheck Phiri, Ruth Nhema, Godfrey Musoro, Vivian Mumbiro, Moses Chitsamatanga, Joy Chimhanzi, Shirley Mutsai, Dorcas Murungu, Wendy Mapfumo, Musakanya Ching’andu, Francesca Viero, Susan Cleary, Lucy Cunnama, Mutsawashe Chitando, Paolo Denti, Roeland Wasmann, Manna Semere Gebreyesus, Jennie van Dyk, Günther Fink, Gillian Levine, D. Ellis, Kamla Pillay, Louise Hill, Tatiana Múnera‐Huertas, Jan Goelen, Clare Shakeshaft
Cited by: 3
References: 32

Abstract

BACKGROUND: WHO recommends 5 days of intravenous antibiotics for children hospitalised with severe community-acquired pneumonia (CAP). We aimed to investigate the safety of a step-down to different oral antibiotics and the shortest effective duration. METHODS: PediCAP was an open-label, parallel group, 2 × 5 factorial randomised controlled trial of children aged 2 months to 6 years hospitalised with severe CAP without complicating factors in 13 hospitals across five sub-Saharan African countries. Children weighing 3-30 kg and with point-of-care C-reactive protein of more than 10 mg/L were randomly assigned (5:5:1) to either a step-down from intravenous antibiotics to oral amoxicillin (250 mg) or amoxicillin-clavulanate (co-amoxiclav; 200 mg amoxicillin to 28·5 mg clavulanate) via dispersible tablets twice daily (superiority comparison) for five total (intravenous plus oral) durations (4-8 days; non-inferiority comparison), or a 5-day, fixed-duration, intravenous-only treatment (non-inferiority comparison). Children were stepped down when clinically improved and able to take oral antibiotics. Clinicians could change antibiotics if clinically indicated. The primary outcome was the proportion of readmission or death at day 28 (non-inferiority margin vs intravenous only: +10%). The study was registered with the ISRCTN registry (ISRCTN63115131) and is complete. FINDINGS: Between Dec 7, 2020, and Aug 14, 2023, 2248 children were screened for eligibility and 1101 were randomly allocated (480 [43·6%] girls and 621 [56·4%] boys). The primary outcome was available in 1055 (95·8%) children. For children in the step-down groups, the mean total antibiotic exposure was 6·0 days (SD 3·5) in the 4-day group, 6·8 days (4·2) in the 5-day group, 7·4 (3·6) in the 6-day group, 8·3 days (3·4) in the 7-day group, and 9·2 days (2·9) in the 8-day group (p

Fields of Study & Subjects

Pneumonia and Respiratory Infections Antibiotic Use and Resistance Nosocomial Infections in ICU

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
408
Issue
10554
Pages
545–557
Publication date
23 July 2026
Language
EN